Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Active human immunodeficiency virus protease is required for viral infectivityN E Kohl, E A Emini, W A Schleif, et al.The Journal of Biological Chemistry|April 15, 1993
Selective inhibition of farnesyl-protein transferase blocks ras processing in vivoJ B Gibbs, D L Pompliano, S D Mosser, et al.Prostate Cancer and Prostatic Diseases|December 24, 2002
Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancerL Sepp-Lorenzino, G Tjaden, M M Moasser, et al.The Journal of Biological Chemistry|October 5, 1991
Structural homology among mammalian and Saccharomyces cerevisiae isoprenyl-protein transferasesN E Kohl, R E Diehl, M D Schaber, et al.Biochemistry|March 1, 1994
Human immunodeficiency virus type 1 protease inhibitors: evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding siteV V Sardana, A J Schlabach, P Graham, et al.Nature Medicine|August 1, 1995
Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic miceN E Kohl, C A Omer, M W Conner, et al.Journal of Medicinal Chemistry|September 29, 1995
Pseudodipeptide inhibitors of protein farnesyltransferaseS J deSolms, A A Deana, E A Giuliani, et al.Journal of Medicinal Chemistry|March 18, 1994
Pseudopeptide inhibitors of Ras farnesyl-protein transferaseS L Graham, S J deSolms, E A Giuliani, et al.Proceedings of the National Academy of Sciences of the United States of America|September 13, 1994
Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude miceN E Kohl, F R Wilson, S D Mosser, et al.Science (New York, N.Y.)|June 25, 1993
Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitorN E Kohl, S D Mosser, S J deSolms, et al.Pageof 6